STERIALS

The company is engaged in the research, development, manufacture and sale of products for the treatment of skin diseases such as non-melanoma skin cancer and keloids, both in the U.S. and overseas. Its proprietary low-energy x-ray technology, superficial radiation therapy, eliminates the need for anesthesia and skin grafts and is particularly effective in treating primary lesions in sensitive areas of the head and neck, such as the eyelids, lips and corners of the mouth. It is a Delaware resident.